Inari Medical Inc. (NARI)
79.97
0.00 (0.00%)
At close: Feb 18, 2025, 3:59 PM
0.00% (1D)
| Bid | 79.97 |
| Market Cap | 4.68B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.35 |
| PE Ratio (ttm) | -59.24 |
| Forward PE | 304.2 |
| Analyst | Hold |
| Ask | 79.99 |
| Volume | 2,356,692 |
| Avg. Volume (20D) | 2,380,732 |
| Open | 79.96 |
| Previous Close | 79.97 |
| Day's Range | 79.96 - 79.97 |
| 52-Week Range | 36.73 - 79.99 |
| Beta | 1.03 |
About NARI
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombecto...
Industry Medical - Devices
Sector Healthcare
IPO Date May 22, 2020
Employees 1,300
Stock Exchange NASDAQ
Ticker Symbol NARI
Website https://www.inarimedical.com
Analyst Forecast
According to 12 analyst ratings, the average rating for NARI stock is "Hold." The 12-month stock price forecast is $75, which is a decrease of -6.21% from the latest price.
Stock ForecastsNext Earnings Release
Inari Medical Inc. is scheduled to release its earnings on Mar 11, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+22.23%
Inari Medical shares are trading higher after Stry...
Unlock content with
Pro Subscription
2 months ago
+30.6%
Inari Medical shares are trading higher following a Reuters report suggesting Stryker is nearing a deal to acquire the company.
